Research News and Research

RSS

House health bill: Texas lawmakers seek to protect hospitals, Hawaii gets an exemption

Employers in Hawaii are required to pay 98.5 percent of the health insurance costs of full-time workers, an arrangement that has earned the state an exemption from the employer mandate in health reform bill being considered by the House of Representatives, the Associated Press reports.

6 Nov 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

6 Nov 2009

Dingell plays powerful and historical health care role

NPR examines the historical role that Rep. John Dingell has played in health care policy, including the establishment of Medicare: "When people think of health care and Congress, often the first name that springs to mind is the late Sen. Edward Kennedy of Massachusetts.

6 Nov 2009

National Institutes of Health grants $6-million for brain disease research

Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.

6 Nov 2009

Facet Solutions announces Archus Orthopedics acquisition

Facet Solutions, Inc. announced today that it has acquired all of the assets of Archus Orthopedics. The acquisition creates an undisputed leadership position in product offerings, intellectual property and clinical experience in posterior motion preservation. "This is a win for patients suffering from lumbar spinal stenosis," stated Facet Solutions' President & CEO, Geoff Pardo. "This consolidation further strengthens Facet Solutions' position in lumbar spine motion preservation surgery, which is the fastest growing sector of the surgical spine marketplace."

6 Nov 2009

CVS investigated by FTC over business practices

"CVS Caremark Corp (CVS.N) has been the subject of a U.S. Federal Trade Commission investigation over some of its business practices since August, the company said on Thursday," Reuters reports. "Various groups have asked the government to look into CVS Caremark's practices since drugstore chain CVS bought pharmacy benefits management business Caremark Rx Inc in March 2007. They claim that changes to services in the pharmacy benefits business since the acquisition have led to higher prices, compromised quality of care and pushed patients to choose CVS drugstores over other pharmacies."

6 Nov 2009

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

Fifty-five percent of the adult population in the Greater Washington, DC region say they will not get the H1N1 flu vaccine, according to a new poll commissioned by the Greater Washington Board of Trade.

6 Nov 2009

H1N1 is now most dominant flu strain worldwide, WHO says

The H1N1 (swine flu) virus is now the dominant flu strain worldwide, the WHO reported Thursday, with the virus accounting for up to 70 percent of the flu viruses sampled in some countries, the Associated Press reports.

6 Nov 2009

Californians who lose jobs find health care safety net badly frayed

In this article for Kaiser Health News, Janet Wilson focuses on California and reports on how the safety net is fraying as economic woes take their toll on state budgets. "With a nip here and a slash there, California's budget crisis is now affecting health care for millions of residents, from wealthy Orange County to the struggling city of Oakland.

6 Nov 2009

ART as part of HIV prevention strategy supported by WHO

"AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said," following a three-day meeting on the topic of using antiretroviral therapy (ART) to help prevent the spread of HIV, Bloomberg reports. "Providing more antiretroviral drugs 'will achieve a significant transmission benefit,' Teguest Guerma, interim director of the WHO's AIDS department, said … 'In the past, there has been a false dichotomy between prevention and treatment. …'That is really what has been corrected. Prevention and treatment are two faces of the same coin'" (Bennett, 11/5).

6 Nov 2009

Bill to extend COBRA subsidies introduced in Senate

Senators introduced legislation Thursday to extend COBRA to help unemployed workers and their families with health coverage. WKYC-TV, a NBC affiliate in Ohio, reports. "U.S. Sens. Sherrod Brown (D-OH) and Robert P. Casey (D-PA) introduced a bill Thursday to extend the 'COBRA' subsidy which helps unemployed workers and their families afford temporary health care [coverage].

6 Nov 2009

Marriott hotels continues to support Children’s Miracle Network hospitals, hosts benefit Torch Relay

Representatives from Marriott hotels throughout the Washington, DC, area, along with co-workers, customers friends and family, joined forces last week to participate in a Torch Relay to benefit Children’s Miracle Network.

6 Nov 2009

Asthma associated with both genetics and environmental exposures

While progress has been made in identifying genes associated with asthma, the disease is complex, and its development is likely dependent upon both genetics and environmental exposures, according to a leading expert presenting at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

6 Nov 2009

Third-quarter 2009 financial results announced by Inhibitex

Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

First Edition: October 6, 2009

Today's headlines highlight activity on different fronts -- with House Democrats scrambling to hold together fragile support for tomorrow's health bill vote while Republican lawmakers and other health reform opponents intensify their attack.

6 Nov 2009

UTSA releases its newest research numbers

The University of Texas at San Antonio (UTSA) released its newest research numbers today, reporting a 34% increase to $46,521,487 in total research spending for the Sept. 1, 2008 – Aug. 31, 2009 fiscal year (FY 09) over the previous fiscal year, when research spending totaled $34,601,444. The statistic is up 97% from just five years ago, when UTSA’s total research expenditures were $23,605,844.

6 Nov 2009

One in three asthma patients are hospitalized, reveals new national survey

In the past year, an estimated more than one million patients were hospitalized and nearly three million visited emergency rooms in the United States as a result of asthma, according to a new comprehensive national survey.

6 Nov 2009

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Are you a female athlete - or just someone who likes challenging workouts -- who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.

6 Nov 2009

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.

6 Nov 2009